Table 3.
The pulmonary function assessment in rats with COPD.
| Group | FEV0.3/FVC (%) | Cdyn (mL/cmH2O) | RI (cmH2O/mL/s) |
|---|---|---|---|
| Control | 88.96 ± 8.83 | 0.50 ± 0.06 | 0.11 ± 0.03 |
| Model | 58.64 ± 4.12▲▲ | 0.33 ± 0.04▲ | 0.21 ± 0.03▲▲ |
| PSR-low dose | 62.94 ± 5.18 | 0.37 ± 0.04 | 0.19 ± 0.02 |
| PSR-medium dose | 70.04 ± 6.54 | 0.40 ± 0.05 | 0.16 ± 0.03 |
| PSR-high dose | 72.52 ± 7.02★ | 0.42 ± 0.04★ | 0.12 ± 0.02★★ |
| Biostime Probiotic Powder | 64.65 ± 6.30 | 0.41 ± 0.05 | 0.14 ± 0.02★ |
COPD: chronic obstructive pulmonary disease; Cdyn: dynamic lung compliance; RI: resistance of inspiration; PSR: Peitu Shengjin Recipe. ▲P < 0.05 and ▲▲P < 0.01 vs. the control group; ★P < 0.05 and ★★P < 0.01 vs. the model group.